The New England journal of medicine, 2023-02, Vol.388 (5), p.478-479
2023
Details
- Autor(en) / Beteiligte
- Titel
- Multiple Cerebral Hemorrhages in a Patient Receiving Lecanemab and Treated with t-PA for Stroke
- Ist Teil von
- The New England journal of medicine, 2023-02, Vol.388 (5), p.478-479
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2023
- Link zum Volltext
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- A patient with mild cognitive impairment who was treated in the extension phase of a trial of lecanemab, an antiamyloid compound, had multiple cerebral hemorrhages during infusion of t-PA for acute stroke.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMc2215148Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10228637
- Format
- –
- Schlagworte
- Aging, Alzheimer Disease, Alzheimer's disease, Antibodies, Monoclonal, Humanized - adverse effects, Antibodies, Monoclonal, Humanized - therapeutic use, Aphasia, Blood pressure, Blood vessels, Brain Ischemia - diagnostic imaging, Brain Ischemia - drug therapy, Cerebral Hemorrhage - chemically induced, Cerebral Hemorrhage - diagnostic imaging, Cognitive ability, Dementia, Edema, Fibrinolytic Agents - adverse effects, Fibrinolytic Agents - therapeutic use, Geriatrics, Humans, Intracranial Hemorrhages - chemically induced, Intracranial Hemorrhages - diagnostic imaging, Magnetic resonance imaging, Neurology, Neurosurgery, Psychiatry, Psychiatry General, Radiology, Radiology General, Stroke, Stroke - diagnostic imaging, Stroke - drug therapy, Tissue Plasminogen Activator - adverse effects, Tissue Plasminogen Activator - therapeutic use, Treatment Outcome